Liraglutide
Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon Liraglutid
Novo Nordisk · Phase 3 · Terminated · Enrollment 2
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| GLP-1 (Liraglutide) | Obesity or overweight | n/r | 9 | n/r | n/r |
| Placebo Comparator | Obesity or overweight | n/r | 9 | n/r | n/r |